Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

CGRP in rat mesenteric artery and vein - receptor expression, CGRP presence and potential roles

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The effects of CGRP in vascular tissue - Classical vasodilation, shadowed effects and systemic dilemmas

    Research output: Contribution to journalReviewResearchpeer-review

  2. Gasotransmitters and the immune system: Mode of action and novel therapeutic targets

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Repair-related molecular changes during recovery phase of ischemic stroke in female rats

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Changes in P2Y6 receptor-mediated vasoreactivity following focal and global ischemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Ny medicin beskytter hjernen ved voldsomme hjerneblødninger hos rotter og hunde - nu bliver den testet på danske patienter

    Research output: Contribution to journalContribution to newspaper - Newspaper articleCommunication

  4. Dual action of the cannabinoid receptor 1 ligand arachidonyl-2'-chloroethylamide on calcitonin gene-related peptide release

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT1 receptors

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

CGRP is a potent dilator of arteries and despite rich perivascular CGRP immunoreactivity in both arteries and veins the role of CGRP in veins remains unknown. The aim of the current study was to compare perivascular CGRP immunoreactivity and expression of CGRP receptor mRNA and CGRP receptor immunoreactivity in rat mesenteric arteries and veins. Furthermore, potential vasomotor effects of CGRP were explored in veins. Immunohistochemical studies reproduced rich perivascular CGRP innervation in arteries and in veins. Further, the presence of mRNA encoding the CGRP receptor subunits, CLR and RAMP1, were demonstrated in both arteries and veins using qPCR. Before comparing the vasoactive effects of CGRP in arteries and veins, we aimed to identify an experimental setting where vasomotor responses could be detected. Therefore, a length-tension study was performed in artery and vein segments. Whereas the arteries showed the characteristic monophasic curve with an IC/IC100 value of 0.9, surprisingly the veins showed a biphasic response with two corresponding IC/IC100 values of 0.7 and 0.9, respectively. There was no significant difference between fresh and cultured vasculature segments. To investigate whether a potential tension-dependent CGRP-induced dilation of veins caused the decline between the two IC/IC100 peaks, a second study was performed, with the CGRP receptor antagonist, BIBN4096BS (olcegepant) and the sensory nerve secretagogue, capsaicin. No significant vascular role of endogenous perivascular CGRP in mesenteric veins could be concluded, and a potential role of the rich perivascular CGRP and CGRP receptor abundancy in veins remains unknown.

Original languageEnglish
JournalEuropean Journal of Pharmacology
Pages (from-to)173033
Publication statusPublished - 15 May 2020

Bibliographical note

Copyright © 2020 Elsevier B.V. All rights reserved.

    Research areas

  • Artery, CGRP, Immunohistochemistry, Length-tension, qPCR, Vein

ID: 59451336